CoCensys Inc.: The company’s stock gained 22%...

CoCensys Inc.: The company’s stock gained 22% Thursday after the biopharmaceutical company announced that it will introduce four psychiatric drugs on an accelerated schedule. CoCensys closed at $3.75 a share, up 69 cents, in heavy Nasdaq trading.

The Irvine-based company said it has completed recruitment of its sales and marketing force ahead of schedule and will actively start promoting the new line of central nervous system drugs on Aug. 1.